The Greater Cannabis Company, Inc. (GCAN)

USD 0.0

(0.0%)

Market Cap (In USD)

402.31 Thousand

Revenue (In USD)

-

Net Income (In USD)

-188.4 Thousand

Avg. Volume

1.1 Million

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
4.0E-4-0.00125
PE
-
EPS
-
Beta Value
1.657
ISIN
US3916571033
CUSIP
391657103
CIK
1695473
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Aitan Zacharin
Employee Count
-
Website
https://www.gcanrx.com
Ipo Date
2018-09-18
Details
The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company was founded in 2014 and is based in Baltimore, Maryland.